...
首页> 外文期刊>Journal of Medicinal Chemistry >Information Decay in Molecular Docking Screens against Holo, Apo, and Modeled Conformations of Enzymes
【24h】

Information Decay in Molecular Docking Screens against Holo, Apo, and Modeled Conformations of Enzymes

机译:分子对接屏幕中针对Holo,Apo和建模酶构型的信息衰减

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Molecular docking uses the three-dimensional structure of a receptor to screen a small molecule database for potential ligands. The dependence of docking screens on the conformation of the binding site remains an open question. To evaluate the information loss that occurs as the active site conformation becomes less defined, a small molecule database was docked against the holo (ligand bound), apo, and homology modeled structures of 10 different enzyme binding sites. The holo and apo representations were crystallographic structures taken from the Protein Data Bank (PDB), and the homology-modeled structures were taken from the publicly available resource ModBase. The database docked was the MDL Drug Data Report (MDDR), a functionally annotated database of 95 000 small molecules that contained at least 35 ligands for each of the 10 systems. In all sites, at least 99% of the molecules in the MDDR were treated as nonbinding decoys. For each system, the holo, apo, and modeled structures were used to screen the MDDR, and the ability of each structure to enrich the known ligands for that system over random selection was evaluated. The best overall enrichment was produced by the holo structure is seven systems, the apo structure in two systems, and the modeled structure in one system. These results suggest that the performance of the docking calculation is affected by the particular representation of the receptor used in the screen, and that the holo structure is the one most likely to yield the best discrimination between known ligands and decoy molecules, but important exceptions to this rule also emerge from this study. Although each of the holo, apo, and modeled conformations led to enrichment of known ligands in all systems, the enrichment did not always rise to a level judged to be sufficient to justify the effort of a docking screen. Using a 20-fold enrichment of known ligands over random selection as a rough guideline for what might be enough to justify a docking screen, the holo conformation of the enzyme met this criterion in eight of 10 sites, whereas the apo conformation met this criterion in only two sites and the modeled conformation in three.
机译:分子对接使用受体的三维结构来筛选小分子数据库中潜在的配体。对接筛选对结合位点构象的依赖性仍然是一个悬而未决的问题。为了评估随着活性位点构象的定义变少而发生的信息丢失,将一个小分子数据库对接了10个不同酶结合位点的整体(配体结合),载脂蛋白和同源性建模结构。全息和载脂蛋白表示是从蛋白质数据库(PDB)取得的晶体结构,而同源性建模的结构是从可公开获得的资源ModBase中取得的。停靠的数据库是MDL药物数据报告(MDDR),这是一个功能注释的数据库,包含95 000个小分子,其中10个系统中的每个系统至少包含35个配体。在所有位点中,MDDR中至少99%的分子被视为非结合诱饵。对于每个系统,使用整体,脱辅基和建模结构筛选MDDR,并评估每个结构在随机选择下富集该系统已知配体的能力。整体结构产生的最佳总体富集是七个系统,两个系统中的apo结构,一个系统中的建模结构。这些结果表明,对接计算的性能受屏幕中所用受体的特定表示影响,并且整体结构是最有可能在已知配体和诱饵分子之间产生最佳区分的结构,但是这个规则也来自这项研究。尽管每个完整的,载脂蛋白和建模的构象均导致所有系统中已知配体的富集,但富集并不总是上升到被认为足以证明对接筛选工作合理的水平。在随机选择中使用已知配体的20倍富集作为可能足以证明对接筛选合理的粗略准则,该酶的整体构象在10个位点中的8个位点均满足该标准,而apo构象在10个位点中均满足该条件。只有两个位点,而建模构象在三个位点。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号